AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 12, 2023
The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly’s highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful – and lucrative – new obesity medicines.
Bio Pharma Dive
NOVEMBER 12, 2023
Early clinical trial results are the first for a base editing treatment and show Verve’s therapy can substantially lower cholesterol levels by editing the genes of liver cells.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 12, 2023
AHA: Wegovy improves survival in outcomes trial Phil.
Drug Patent Watch
NOVEMBER 12, 2023
In a recent article in Pharmaceutical Executive, Alan Kalton, Senior Vice President of Commercial Strategy at Aktana, sheds light on the critical challenges facing pharmaceutical companies as they confront impending… The post AI-Driven Strategies: Pharma’s Answer to Patent Expirations appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
JAMA Internal Medicine
NOVEMBER 12, 2023
This study examines whether artificial intelligence (AI) models can be manipulated for the generation of targeted health disinformation regarding vaccines and vaping.
Drug Patent Watch
NOVEMBER 12, 2023
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
JAMA Internal Medicine
NOVEMBER 12, 2023
The COVID-19 pandemic devastated the population of the US, causing over 1 million deaths and an even greater number of hospitalizations or cases of post–COVID-19 condition (also referred to colloquially as long COVID), but perhaps the most sorrowful remembrance will be the unnecessary losses in lives. Even after messenger RNA vaccines became widely available by the spring of 2021, the COVID-19 deaths continued to climb because of widescale vaccine refusal.
BioSpace
NOVEMBER 12, 2023
Harnessing Social Media for Clinical Trial Recruitment - read this article along with other careers information, tips and advice on BioSpace
JAMA Internal Medicine
NOVEMBER 12, 2023
This cross-sectional study systematically examines the contributions of COVID-19 and other underlying causes of death to the widened gender life expectancy gap from 2010 to 2021.
BioSpace
NOVEMBER 12, 2023
At its highest dose level of 608 mg, lepodisiran reduced lipoprotein(a) levels by a median of 94% after 48 weeks.
JAMA Internal Medicine
NOVEMBER 12, 2023
This essay describes how a podcast inspired a physician’s new approach to complimenting patients and colleagues and the benefits gained.
BioSpace
NOVEMBER 12, 2023
Novo Nordisk posted new data at AHA 2023 showing that its blockbuster weight loss drug could cut the risk of major cardiovascular events—including heart attack—across patient subgroups.
JAMA Internal Medicine
NOVEMBER 12, 2023
This JAMA Internal Medicine Patient Page reviews sciatica, its symptoms, and treatment options for those who have it.
BioSpace
NOVEMBER 12, 2023
When given at potentially therapeutic doses, Verve’s base editor led to strong reductions in LDL cholesterol and PCSK9 levels in patients with heterozygous familial hypercholesterolemia.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
NOVEMBER 12, 2023
Acetylcysteine is the generic ingredient in seven branded drugs marketed by Cumberland Pharms, Aspen, Eugia Pharma, Exela Pharma, Fresenius Kabi Usa, Indoco, Rising, Sagent Pharms Inc, Steriscience, Zydus Pharms, Alvogen,… The post New tentative approval for Rising drug acetylcysteine appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
NOVEMBER 12, 2023
After success with J&J, Legend strikes another license agreement, this one with Swiss pharma Novartis around CAR-T therapies.
Drug Patent Watch
NOVEMBER 12, 2023
Annual Drug Patent Expirations for SKYLA Skyla is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are six patents… The post New patent expiration for Bayer Hlthcare drug SKYLA appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
NOVEMBER 12, 2023
The UK-based nanomedicine biotech, previously known as SomaServe, has closed its Series A with some significant biopharma names attached.
Drug Patent Watch
NOVEMBER 12, 2023
Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are six patents… The post New patent expiration for Bayer Hlthcare drug KYLEENA appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
NOVEMBER 12, 2023
Over the next two weeks, the FDA is set to decide on New Drug Applications from Pacira, CorMedix and Aldeyra and hold an advisory committee meeting for two overdue confirmatory trials from Acrotech.
Drug Patent Watch
NOVEMBER 12, 2023
AMRIX (cyclobenzaprine hydrochloride) Teva pharms intl Patent: 7,829,121 Expiration: Nov 14, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact… The post Drug Patent Expirations for the Week of November 12, 2023 appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
NOVEMBER 12, 2023
Pennsylvania-based Aclaris Therapeutics will stop development of zunsemetinib after it failed to meet the primary endpoint in a Phase II study for rheumatoid arthritis.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Client Pharma
NOVEMBER 12, 2023
In honour of those who served and sacrificed, we pledge to keep their memory alive with gratitude and reverence. hashtag#RemembranceDay2023 hashtag#RemembranceDay hashtag#LestWeForget The post Remembrance Day appeared first on ClientPharma.
BioSpace
NOVEMBER 12, 2023
As Vertex and CRISPR Therapeutics await the monumental potential approval of exa-cel, bluebird bio, Iovance and Rocket Pharmaceuticals wait patiently in the wings.
Trialfacts
NOVEMBER 12, 2023
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center: Location Research Center: Sonova USA, Inc. Location: Sonova USA, Inc., 47257 Fremont Blvd, Fremont, CA 94538, United States Lead Researcher: Dr. Grace Gardner IRB Committee: This study has been reviewed and approved by the WCG Institutional Review Board About the Study Did you know that approximately 1 in 7 people living in the United States have hearing loss?
Pharma in Brief
NOVEMBER 12, 2023
The Patented Medicine Prices Review Board ( PMPRB ) has released a scoping paper on themes and questions to develop new price review Guidelines. The scoping paper also includes information on how stakeholders can participate in the consultation. The deadline for written submissions addressing the scoping paper is December 20, 2023. Background The PMPRB has not had a full set of Guidelines since July 1, 2022, when amendments to the Patented Medicines Regulations came into force implementing a
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
239 
Let's personalize your content